Back to Screener

LABCORP HOLDINGS INC. (LH)

NYSE Large Cap

Healthcare › Services-Medical Laboratories

$265.84
Market Cap: $21.9B
Data as of Sep 30, 2025 (TTM)

Price History

Feb 9, 2026 — Apr 4, 2026

Investment Snapshot

  • Trading 68% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 7/9 — financially strong with improving fundamentals
  • ROE of 10.2% — below-average profitability
  • Revenue growing at 7% annually

LABCORP HOLDINGS INC. (LH) is a Healthcare company operating in Services-Medical Laboratories, listed on the NYSE , with a market capitalisation of $21.9 billion . Key value metrics: P/E ratio 24.9, P/B ratio 2.54, Piotroski F-Score 7 out of 9 (strong financial health) .

Value Score

Key Metrics

P/E Ratio
24.86
2.54
EPS
$10.69
Div. Yield
1.1%
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

LABCORP HOLDINGS INC. — Fundamental Analysis Summary

LABCORP HOLDINGS INC. (LH) is currently trading 68% above its Graham Number of $158.64, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 24.9x.

On financial health, LH shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 10.2% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.71.

StockPik's composite Value Score for LH is 72/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

LH reports a moderate gross margin of 28.6% (sector average: 33.5%) and a modest operating margin of 10.0%.

LH shows revenue growing at 7% year-over-year, with earnings growing at 17%.

LH pays a modest dividend yield of 1.1%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
CYRX $8.21 4.7 100
CRMD $6.70 3.6 100
CGEN $2.06 5.5 100
ABEO $4.82 4.5 100
BDMD $2.01 5.8 100
High Piotroski F-Score stocks
Other stocks with F-Score ≥ 7 showing broad financial improvement
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
LGVN
Next
LHAI